Article
Potency and efficacy of VP20-based vaccine against tilapia lake virus using different prime-boost vaccination regimens in tilapia
2022-06-01
Abstract excerpt
Tilapia lake virus (TiLV) is a newly emerged pathogen responsible for high mortality and economic losses in the global tilapia industry. Vaccination is the most effective way to prevent and control viral diseases. There is currently no vaccine on the market to control TiLV infections. Recently, we identified that TiLV segment 8 encoded a protein (VP20) with immunogenicity sufficient for use as a vaccine antigen. I...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2bc7af30-0c59-5450-8202-78e02118c4ce
- DOI
- 10.1016/j.aquaculture.2021.736654
